Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma
Status:
Terminated
Trial end date:
2007-11-07
Target enrollment:
Participant gender:
Summary
This research is to test the effectiveness and toxicity of both Ifosfamide and Doxorubicin.
It also aims to explore the relationship between EBV DNA and clinical response in patients
with advanced naso-pharyngeal cancer which has been previously treated with chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins